questionsmedicales.fr
Bactéries
Proteobacteria
Betaproteobacteria
Burkholderiales
Burkholderiaceae
Burkholderiaceae : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Burkholderiaceae : Questions médicales les plus fréquentes",
"headline": "Burkholderiaceae : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Burkholderiaceae : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-16",
"dateModified": "2025-03-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Burkholderiaceae"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Burkholderiales",
"url": "https://questionsmedicales.fr/mesh/D000073556",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderiales",
"code": {
"@type": "MedicalCode",
"code": "D000073556",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Burkholderia",
"alternateName": "Burkholderia",
"url": "https://questionsmedicales.fr/mesh/D019117",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia",
"code": {
"@type": "MedicalCode",
"code": "D019117",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Burkholderia cepacia complex",
"alternateName": "Burkholderia cepacia complex",
"url": "https://questionsmedicales.fr/mesh/D042602",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia cepacia complex",
"code": {
"@type": "MedicalCode",
"code": "D042602",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.110"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Burkholderia cenocepacia",
"alternateName": "Burkholderia cenocepacia",
"url": "https://questionsmedicales.fr/mesh/D057508",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia cenocepacia",
"code": {
"@type": "MedicalCode",
"code": "D057508",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.110.490"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Burkholderia cepacia",
"alternateName": "Burkholderia cepacia",
"url": "https://questionsmedicales.fr/mesh/D016956",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia cepacia",
"code": {
"@type": "MedicalCode",
"code": "D016956",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.110.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Burkholderia cenocepacia",
"alternateName": "Burkholderia cenocepacia",
"url": "https://questionsmedicales.fr/mesh/D057508",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia cenocepacia",
"code": {
"@type": "MedicalCode",
"code": "D057508",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.110.490"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Burkholderia cepacia",
"alternateName": "Burkholderia cepacia",
"url": "https://questionsmedicales.fr/mesh/D016956",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia cepacia",
"code": {
"@type": "MedicalCode",
"code": "D016956",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.110.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Burkholderia gladioli",
"alternateName": "Burkholderia gladioli",
"url": "https://questionsmedicales.fr/mesh/D042725",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia gladioli",
"code": {
"@type": "MedicalCode",
"code": "D042725",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.355"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Burkholderia mallei",
"alternateName": "Burkholderia mallei",
"url": "https://questionsmedicales.fr/mesh/D042726",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia mallei",
"code": {
"@type": "MedicalCode",
"code": "D042726",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.477"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Burkholderia pseudomallei",
"alternateName": "Burkholderia pseudomallei",
"url": "https://questionsmedicales.fr/mesh/D016957",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia pseudomallei",
"code": {
"@type": "MedicalCode",
"code": "D016957",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.600"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Cupriavidus",
"alternateName": "Cupriavidus",
"url": "https://questionsmedicales.fr/mesh/D049921",
"about": {
"@type": "MedicalCondition",
"name": "Cupriavidus",
"code": {
"@type": "MedicalCode",
"code": "D049921",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.200"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cupriavidus necator",
"alternateName": "Cupriavidus necator",
"url": "https://questionsmedicales.fr/mesh/D020118",
"about": {
"@type": "MedicalCondition",
"name": "Cupriavidus necator",
"code": {
"@type": "MedicalCode",
"code": "D020118",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.200.200"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Ralstonia",
"alternateName": "Ralstonia",
"url": "https://questionsmedicales.fr/mesh/D043367",
"about": {
"@type": "MedicalCondition",
"name": "Ralstonia",
"code": {
"@type": "MedicalCode",
"code": "D043367",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.600"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Ralstonia pickettii",
"alternateName": "Ralstonia pickettii",
"url": "https://questionsmedicales.fr/mesh/D049920",
"about": {
"@type": "MedicalCondition",
"name": "Ralstonia pickettii",
"code": {
"@type": "MedicalCode",
"code": "D049920",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.600.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ralstonia solanacearum",
"alternateName": "Ralstonia solanacearum",
"url": "https://questionsmedicales.fr/mesh/D043368",
"about": {
"@type": "MedicalCondition",
"name": "Ralstonia solanacearum",
"code": {
"@type": "MedicalCode",
"code": "D043368",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.600.750"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Burkholderiaceae",
"alternateName": "Burkholderiaceae",
"code": {
"@type": "MedicalCode",
"code": "D042521",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Yusuke Takashima",
"url": "https://questionsmedicales.fr/author/Yusuke%20Takashima",
"affiliation": {
"@type": "Organization",
"name": "United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology."
}
},
{
"@type": "Person",
"name": "Yousuke Degawa",
"url": "https://questionsmedicales.fr/author/Yousuke%20Degawa",
"affiliation": {
"@type": "Organization",
"name": "Sugadaira Research Station Mountain Science Center, University of Tsukuba."
}
},
{
"@type": "Person",
"name": "Tomoyasu Nishizawa",
"url": "https://questionsmedicales.fr/author/Tomoyasu%20Nishizawa",
"affiliation": {
"@type": "Organization",
"name": "United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology."
}
},
{
"@type": "Person",
"name": "Hiroyuki Ohta",
"url": "https://questionsmedicales.fr/author/Hiroyuki%20Ohta",
"affiliation": {
"@type": "Organization",
"name": "United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology."
}
},
{
"@type": "Person",
"name": "Kazuhiko Narisawa",
"url": "https://questionsmedicales.fr/author/Kazuhiko%20Narisawa",
"affiliation": {
"@type": "Organization",
"name": "United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Leveraging Implementation Science for Cardiovascular Health Equity: A Scientific Statement From the American Heart Association.",
"datePublished": "2022-10-10",
"url": "https://questionsmedicales.fr/article/36214131",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1161/CIR.0000000000001096"
}
},
{
"@type": "ScholarlyArticle",
"name": "Building implementation science capacity among practitioners of cancer control: development of a pilot training curriculum.",
"datePublished": "2022-07-17",
"url": "https://questionsmedicales.fr/article/35842850",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10552-022-01604-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Perspective: leveraging review protocols to advance implementation science in support of older adults' health equity.",
"datePublished": "2024-10-11",
"url": "https://questionsmedicales.fr/article/39463900",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fpubh.2024.1457591"
}
},
{
"@type": "ScholarlyArticle",
"name": "Building CapaCITY/É for sustainable transportation: protocol for an implementation science research program in healthy cities.",
"datePublished": "2024-04-17",
"url": "https://questionsmedicales.fr/article/38631827",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bmjopen-2024-085850"
}
},
{
"@type": "ScholarlyArticle",
"name": "Implementation Science Fundamentals: Pediatric Surgery Enhanced Recovery After Surgery Protocol for Pectus Repair.",
"datePublished": "2022-11-21",
"url": "https://questionsmedicales.fr/article/36423481",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jss.2022.10.018"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Bactéries",
"item": "https://questionsmedicales.fr/mesh/D001419"
},
{
"@type": "ListItem",
"position": 3,
"name": "Proteobacteria",
"item": "https://questionsmedicales.fr/mesh/D020560"
},
{
"@type": "ListItem",
"position": 4,
"name": "Betaproteobacteria",
"item": "https://questionsmedicales.fr/mesh/D020562"
},
{
"@type": "ListItem",
"position": 5,
"name": "Burkholderiales",
"item": "https://questionsmedicales.fr/mesh/D000073556"
},
{
"@type": "ListItem",
"position": 6,
"name": "Burkholderiaceae",
"item": "https://questionsmedicales.fr/mesh/D042521"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Burkholderiaceae - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Burkholderiaceae",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Burkholderiaceae",
"description": "Comment diagnostiquer une infection par Burkholderiaceae ?\nQuels tests sont utilisés pour identifier Burkholderia ?\nLes symptômes aident-ils au diagnostic ?\nLes tests sérologiques sont-ils utiles ?\nQuelle est l'importance de l'antibiogramme ?",
"url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Implementation+Science&page=7#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Burkholderiaceae",
"description": "Quels sont les symptômes d'une infection par Burkholderia ?\nLes infections pulmonaires sont-elles fréquentes ?\nBurkholderia peut-elle causer des infections cutanées ?\nY a-t-il des symptômes neurologiques associés ?\nLes symptômes varient-ils selon le type de Burkholderia ?",
"url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Implementation+Science&page=7#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Burkholderiaceae",
"description": "Comment prévenir les infections par Burkholderia ?\nLes vaccinations sont-elles efficaces ?\nLes personnes à risque doivent-elles être surveillées ?\nLes mesures d'hygiène hospitalière sont-elles importantes ?\nLes équipements de protection individuelle sont-ils nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Implementation+Science&page=7#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Burkholderiaceae",
"description": "Quel est le traitement standard pour les infections par Burkholderia ?\nLes infections sont-elles résistantes aux antibiotiques ?\nDes traitements alternatifs existent-ils ?\nLe traitement préventif est-il possible ?\nQuelle est la durée du traitement antibiotique ?",
"url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Implementation+Science&page=7#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Burkholderiaceae",
"description": "Quelles sont les complications possibles d'une infection par Burkholderia ?\nLes infections peuvent-elles être mortelles ?\nY a-t-il des complications neurologiques ?\nLes infections peuvent-elles entraîner des hospitalisations prolongées ?\nQuelles sont les séquelles possibles après une infection ?",
"url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Implementation+Science&page=7#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Burkholderiaceae",
"description": "Quels sont les principaux facteurs de risque d'infection ?\nLes patients atteints de cysticfibrose sont-ils à risque ?\nLes personnes âgées sont-elles plus à risque ?\nLes travailleurs de la santé sont-ils exposés ?\nLes voyages dans certaines régions augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Implementation+Science&page=7#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection par Burkholderiaceae ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des cultures bactériennes et des tests de sensibilité aux antibiotiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour identifier Burkholderia ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests PCR et des séquençages génétiques sont souvent utilisés pour l'identification."
}
},
{
"@type": "Question",
"name": "Les symptômes aident-ils au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes cliniques peuvent orienter vers une infection, mais ne suffisent pas."
}
},
{
"@type": "Question",
"name": "Les tests sérologiques sont-ils utiles ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sérologiques peuvent aider, mais ne sont pas toujours fiables pour Burkholderia."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'antibiogramme ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'antibiogramme est crucial pour déterminer la sensibilité aux antibiotiques des souches isolées."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une infection par Burkholderia ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, toux, douleurs thoraciques et parfois des lésions cutanées."
}
},
{
"@type": "Question",
"name": "Les infections pulmonaires sont-elles fréquentes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections pulmonaires, notamment chez les patients immunodéprimés, sont courantes."
}
},
{
"@type": "Question",
"name": "Burkholderia peut-elle causer des infections cutanées ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des infections cutanées peuvent survenir, surtout après des blessures ou des brûlures."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes neurologiques peuvent apparaître, mais ils sont moins fréquents et souvent graves."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de Burkholderia ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon l'espèce de Burkholderia et l'état du patient."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections par Burkholderia ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut une bonne hygiène, des soins appropriés des plaies et l'évitement des contacts à risque."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles efficaces ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccins spécifiques contre les infections par Burkholderia."
}
},
{
"@type": "Question",
"name": "Les personnes à risque doivent-elles être surveillées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunodéprimées ou avec des maladies chroniques doivent être surveillées de près."
}
},
{
"@type": "Question",
"name": "Les mesures d'hygiène hospitalière sont-elles importantes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des mesures strictes d'hygiène hospitalière sont essentielles pour prévenir les infections nosocomiales."
}
},
{
"@type": "Question",
"name": "Les équipements de protection individuelle sont-ils nécessaires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'utilisation d'équipements de protection individuelle est recommandée dans les milieux à risque."
}
},
{
"@type": "Question",
"name": "Quel est le traitement standard pour les infections par Burkholderia ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement standard inclut des antibiotiques comme la céftazidime ou le meropenem."
}
},
{
"@type": "Question",
"name": "Les infections sont-elles résistantes aux antibiotiques ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines souches de Burkholderia montrent une résistance significative aux antibiotiques."
}
},
{
"@type": "Question",
"name": "Des traitements alternatifs existent-ils ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements alternatifs peuvent inclure des combinaisons d'antibiotiques ou des thérapies ciblées."
}
},
{
"@type": "Question",
"name": "Le traitement préventif est-il possible ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un traitement préventif peut être envisagé pour les patients à risque élevé d'infection."
}
},
{
"@type": "Question",
"name": "Quelle est la durée du traitement antibiotique ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La durée du traitement varie, mais elle est généralement de 2 à 4 semaines selon la gravité."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles d'une infection par Burkholderia ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des septicémies, des infections pulmonaires graves et des abcès."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles être mortelles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections par Burkholderia peuvent être mortelles, surtout chez les patients à risque."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications neurologiques ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications neurologiques, bien que rares, peuvent survenir, entraînant des séquelles."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles entraîner des hospitalisations prolongées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections graves par Burkholderia peuvent nécessiter des hospitalisations prolongées."
}
},
{
"@type": "Question",
"name": "Quelles sont les séquelles possibles après une infection ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les séquelles peuvent inclure des problèmes respiratoires chroniques ou des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'infection ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent l'immunodépression, les maladies chroniques et les traumatismes."
}
},
{
"@type": "Question",
"name": "Les patients atteints de cysticfibrose sont-ils à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients atteints de cysticfibrose sont particulièrement vulnérables aux infections par Burkholderia."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées ont un risque accru d'infections en raison d'un système immunitaire affaibli."
}
},
{
"@type": "Question",
"name": "Les travailleurs de la santé sont-ils exposés ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les travailleurs de la santé peuvent être exposés à des souches résistantes dans les hôpitaux."
}
},
{
"@type": "Question",
"name": "Les voyages dans certaines régions augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des régions où Burkholderia est endémique peut augmenter le risque d'infection."
}
}
]
}
]
}
Reducing cardiovascular disease disparities will require a concerted, focused effort to better adopt evidence-based interventions, in particular, those that address social determinants of health, in h...
Cancer control interventions are difficult to implement with fidelity, while tailoring to fit contexts. Engaged approaches are suggested to advance equity. On-the-ground practitioners are needed to se...
The Cancer Control Implementation Science Base Camp (CCISBC) was created to improve capacity among cancer control practitioners when implementing evidence-based cancer screening programs in specific c...
Nine competencies overlapped between four of the curricula scanned in this study, all of which served as the basis for learning objectives. Principles that emerged from design sessions included stayin...
In order to scale practice-based evidence, practitioners will need to be engaged. This engagement is optimized when practitioners are trained to collaborate on implementation research. The CCISBC is a...
Globally, there has been an increasing call for dissemination and implementation science to improve the health equity of older adults. However, improving the health equity of older adults requires met...
Improving sustainable transportation options will help cities tackle growing challenges related to population health, congestion, climate change and inequity. Interventions supporting active transport...
Across nine Canadian municipalities and the State of Victoria (Australia), our research will focus on two types of sustainable transportation interventions: all ages and abilities bicycle networks and...
This study received approval from the Simon Fraser University Office of Ethics Research (H22-03469). A Knowledge Mobilization Hub will coordinate dissemination of findings via a website; presentations...
Surgical repair of pectus excavatum and carinatum in children has historically been associated with severe postoperative pain and prolonged hospitalization. Enhanced Recovery After Surgery (ERAS) is a...
A multidisciplinary team of providers worked collaboratively to develop an ERAS protocol for surgical repair of pectus excavatum and carinatum and methods for identifying eligible patients. The surgic...
Our entire pediatric surgery team, nurses at every stage (clinic/preoperative/recovery/floor), physical therapy, and information technology contributed to the creation and implementation of an ERAS pr...
This is one of the first studies in children which details the step-by-step process of developing and implementing an ERAS protocol for pectus excavatum and carinatum. The process of development and i...
We designed a process to increase tobacco cessation in an academic center and its widely distributed network community sites using clinical champions to overcome referral barriers....
In 2020 a needs assessment was performed across the City of Hope Medical Center and its 32 community treatment sites. We reviewed information science strategies to choose elements for our expanded tob...
Cancer center leadership committed to expanding tobacco control. Funding was obtained through a Cancer Center Cessation Initiative (C3I) grant. Multi-disciplinary leaders developed a comprehensive pla...
An efficient process to expand smoking cessation in the City of Hope network was developed using implementation science strategies and cessation champions. This well-detailed implementation process ma...
Penicillin allergy is the most frequently reported drug allergy, yet most patients can tolerate the drug if challenged. Despite this discrepancy, large scale penicillin allergy de-labeling interventio...
We followed a four-step process that leverages qualitative analysis to design evidence-based, actionable strategies to develop an intervention. First, we specified the clinician-perceived barriers to ...
Evidence-based strategies such as focused education and training in penicillin allergy evaluation can address knowledge and confidence barriers reported by frontline clinicians. Other key strategies i...
Empowering clinicians beyond allergy specialists to conduct penicillin allergy assessments requires designing new workflows and systems and providing additional knowledge to those clinicians....
In 2020, the Health Resources and Services Administration's HIV/AIDS Bureau funded an initiative to promote implementation of rapid antiretroviral therapy initiation in 14 HIV treatment settings acros...
The ETAP has used implementation science methods framed by the Dynamic Capabilities Model integrated with the Conceptual Model of Implementation Research to develop a Hybrid Type II, multi-site mixed-...
This approach will allow us to understand in detail the processes that sites to implement and integrate rapid initiation of antiretroviral therapy as standard of care as a means of achieving equity in...
The vision of the Central Society for Clinical and Translational Research (CSCTR) is to "promote a vibrant, supportive community of multidisciplinary, clinical, and translational medical research to b...
The introduction of traditional, complementary and integrative medicine (TCIM) services into health systems has been advocated by the World Health Organization, but there is a paucity of reviews synth...
The aim of this study was to identify, describe and analyse publications on these two key TCIM policy issues via an overview from an implementation science perspective....
Publications describing international experiences of implementing TCIM services or evidence for TCIM practices were identified by searching MEDLINE, EMBASE and Global Health databases in November 2021...
Sixty-three relevant publications were included in the analysis. Current experiences in China and the United Sates (US) reflect varying policy priorities at different stages of implementing TCIM servi...
Policymakers managing different stages of TCIM implementation will benefit from the experiences of practitioners in the US and China. Multi-level implementation interventions launched in the US provid...